New drug trial offers hope for controlling rare blood disorder
NCT ID NCT03157635
Summary
This early-stage study is testing a new drug called crovalimab for people with paroxysmal nocturnal hemoglobinuria (PNH), a rare and serious blood disease. The main goals are to check if the drug is safe, how the body processes it, and if it can help control the disease. The study involves both healthy volunteers and people with PNH, testing different doses and schedules.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAROXYSMAL HEMOGLOBINURIA, NOCTURNAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut hematologie Centre Hayem CHU paris Saint-Louis Lariboisiere F Widal Hopital St Louis
Paris, 75475, France
-
Kaposi Mor Teaching Hospital, Dept of Internal Medicine/Hematology
Kaposvár, 7400, Hungary
-
NTT Medical Center Tokyo
Tokyo, 141-8625, Japan
-
Osaka University Hospital
Osaka, 565-0871, Japan
-
Policlinico Universitario Agostino Gemelli
Rome, Lazio, 00168, Italy
-
Pra International Group B.V
Groningen, 9713 GZ, Netherlands
-
Semmelweis Egyetem, 1. Szamu Belgyogyaszati Klinika, Diabetologia
Budapest, 1083, Hungary
-
Seoul National University Hosp
Seoul, 110-744, South Korea
-
Tohoku University Hospital
Miyagi, 980-8574, Japan
-
Tokyo Medical University Hospital
Tokyo, 160-0023, Japan
-
Uniklinik RWTH Aachen
Aachen, 52074, Germany
-
University of Tsukuba Hospital
Tsukuba, 305-8576, Japan
-
Universitätsklinikum Essen
Essen, 45122, Germany
-
Universitätsklinikum Ulm
Ulm, 89081, Germany
Conditions
Explore the condition pages connected to this study.